<!doctype html>
<html lang="en-US">
  <head>
  <meta charset="utf-8">
  <meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no">
  <meta name="description" content="Oncosyne: precision in cancer medicine">
  <meta name="author" content="PWE">

	<title>Oncosyne: precision in cancer medicine</title>
	<link rel="icon" href="favicon.ico">

	<meta name="robots"               content="index,follow">
	<meta name="referrer"             content="origin-when-cross-origin">
	<meta name="generator"            content="Hugo 0.80.0" />
	
<!-- ref: https://developers.facebook.com/docs/sharing/webmasters#markup -->

  <meta property="og:url"           content="https://oncosyne.no/" />
  <meta property="og:site_name"     content="Oncosyne" />
  <meta property="og:title"         content="Precision in cancer medicine" />
  <meta property="og:description"   content="Oncosyne is a biotech start-up developing a platform for clinical-grade in vitro diagnostic drug screening. We are based in the Oslo Cancer Cluster Incubator." />
  <meta property="og:image"         content="https://oncosyne.no/img/oncosyne-link-preview.jpg" />
  <meta property="og:image:width"   content="1200"/>
  <meta property="og:image:height"  content="630"/>
  <meta property="og:type"          content="website" />
	
	<link href="https://oncosyne.no/vendor/bootstrap/css/bootstrap.min.css" rel="stylesheet">
	<link href="https://oncosyne.no/vendor/font-awesome/css/font-awesome.min.css" rel="stylesheet" type="text/css">
	<link href="https://fonts.googleapis.com/css?family=Lora:400,700,400italic,700italic" rel="stylesheet" type="text/css">
	<link href='https://fonts.googleapis.com/css?family=Cabin:700' rel='stylesheet' type='text/css'>
	<link href="css/oncosyne.css" rel="stylesheet">

<!-- Navigation bar -->

</head>

<body id="page-top">
<nav class="navbar navbar-expand-lg navbar-light fixed-top" id="mainNav">
 <div class="container">
  <a class="navbar-brand js-scroll-trigger improve-contrast-box" href="#page-top">Precision in cancer medicine</a>
  <button class="navbar-toggler navbar-toggler-right" type="button" data-toggle="collapse" data-target="#navbarResponsive" aria-controls="navbarResponsive" aria-expanded="false" aria-label="Toggle navigation">Menu<i class="fa fa-bars"></i></button>
  <div class="collapse navbar-collapse" id="navbarResponsive">
   <ul class="navbar-nav ml-auto">
    <li class="nav-item">
     <a class="nav-link js-scroll-trigger improve-contrast-box" href="#sec-ind-1">news</a>
    </li>
    <li class="nav-item">
     <a class="nav-link js-scroll-trigger improve-contrast-box" href="#sec-ind-2">about</a>
    </li>
    <li class="nav-item">
      <a class="nav-link js-scroll-trigger improve-contrast-box" href="#sec-ind-3">team</a>
     </li>
     <li class="nav-item">
      <a class="nav-link js-scroll-trigger improve-contrast-box" href="#sec-ind-5">careers</a>
     </li>
    <li class="nav-item">
     <a class="nav-link js-scroll-trigger improve-contrast-box" href="#sec-ind-contact">contact</a>
    </li></ul>
  </div>
 </div>
</nav>
</body>

<!-- ref: Background video -->

<video autoplay muted loop id="background-video" poster="mov/Rolig_BG_bakgrunn.jpeg">
  <!-- <source src="mov/zstack2.webm" type="video/webm">
  <source src="mov/zstack2.mp4" type="video/mp4"> -->
  <source src="mov/Rolig_BG_bakgrunn.webm" type="video/webm">
  <source src="mov/Rolig_BG_bakgrunn.mp4" type="video/mp4"> 
  "browser doesn't support WEBM or MP4 video"
</video>

<!-- SECTION 0 -->

<section id="sec-ind-0" class="section-0 content-section text-center">
  <header>
    <div class="content"><div class="row"><div class="col-lg-8 mx-auto">
      <img class="center-fit glowing", id="logo" src="img/oncosyne-logo.png" alt="oncosyne-logo" width="300" height="46">
      <p>&nbsp;</p>
      <p>functional precision oncology for improved patient healthcare</p>
      <p>&nbsp;</p>
      <a href="#sec-ind-1" class="btn btn-circle js-scroll-trigger" aria-label="Scroll to Next Section"><i class="fa fa-angle-double-down animated"></i></a>
    </div></div></div>
  </header>
</section>

<!-- SECTION 1 -->

<section id="sec-ind-1" class="section-1 content-section text-center">
  <div class="container"><div class="row"><div class="col-lg-8 mx-auto">
  <h2 id="news">News</h2>

  
  <table>
    <thead><tr><th style="text-align:right"></th><th style="text-align:left"></th></tr></thead>
    <tbody>

      <tr>
        <td style="text-align:right"><strong>2024-Oct</strong> We are thrilled to announce that Isofol Medical, Ahus, and Oncosyne got a late-breaking abstract accepted for poster presentation at the <a href="https://event.eortc.org/ena2024/">36th EORTC-NCI-AACR symposium</a> in Barcelona later this month.
          <td style="text-align:left">
          
        </td>
      </tr>
  
      <tr>
        <td style="text-align:right">
            <picture class="center-fit">
              <source type="image/webp" srcset="img/202410_elrig.webp">
              <img src="img/202410_elrig.png" alt="ELRIG Drug Development logo screenshot" width="150px" height="150px">
            </picture>
        </td>
        <td style="text-align:left"><strong>2024-Oct</strong> On behalf Oncosyne and collaborators Dr. Sebastian Meltzer (Ahus) and Dr. Teijo Pellinen (FIMM), Jarle Bruun, Peter W, Eide and Christer A. Andreassen presented a poster entitled <em>μCAN - drug discovery, development and diagnostics using clinical grade drug screening and predictive phenotyping of patient-derived tumoroids</em> at the <a href="https://elrig.org/portfolio/drug-discovery-2024/">ELRIG UK Drug Discovery 2024 conference in London</a>.
    </tr>
  
      <tr>
        <td style="text-align:right"><strong>2024-May</strong> We are hiring! The coming year, we will validate our <em>in vitro</em> diagnostic test, expand to new disease indications and leverage our platform for drug development projects. Please see the <a href="doc/202405_Oncosyne_We are hiring.pdf" target="_blank" rel="noopener noreferrer"> attached advertisement</a> for details.
          <td style="text-align:left">
            <picture class="center-fit">
              <source type="image/png" srcset="img/hiring.png">
              <img src="img/hiring.png" alt="Hiring" width="150px" height="150px">
            </picture>
        </td>
      </tr>
  
    <tr>
        <td style="text-align:right">
            <picture class="center-fit">
              <source type="image/webp" srcset="img/andren-sandberg.webp">
              <img src="img/andren-sandberg.jpeg" alt="Åke Andrén-Sandbeg, Photo: NA" width="150px" height="150px">
            </picture>
        </td>
        <td style="text-align:left"><strong>2024-Mar</strong> Professor Åke Andrén-Sandberg is joining the team as a clinical advisor. Prof Andrén-Sandberg is a specialist in gastro-intestinal surgery with <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%C3%A5ke+andren-sandberg" target="_blank" rel="noopener noreferrer"> research focusing on pancreatic disease</a>.
    </tr>
  

    <tr>
      <td style="text-align:right"><strong>2024-Mar</strong> <a href="https://www.med.uio.no/hth/english/" target="_blank" rel="noopener noreferrer"> Hybrid Technology Hub</a> and Oncosyne held a <a href="https://cellspace.bio/2024/03/05/example-post-two/" target="_blank" rel="noopener noreferrer">kickoff meeting</a> initiating development of Oncosyne's next-generation in vitro diagnostic test for pancreatic cancer. The aim is to start clinical studies later this year.
        <td style="text-align:left">
          <picture class="center-fit">
            <source type="image/webp" srcset="img/202403_pdac-kickoff.webp">
            <img src="img/202403_pdac-kickoff.jpg" alt="HTH representatives and Oncosyne at the latter's lab facilities at Oslo Cancer Cluster Incubator" width="150px" height="150px">
          </picture>
      </td>
    </tr>


    <tr>
        <td style="text-align:right">
            <picture class="center-fit">
              <source type="image/webp" srcset="img/202402_gowest.webp">
              <img src="img/202402_gowest.jpeg" alt="Peter W. Eide presenting, Photo: Jarle Bruun" width="150px" height="150px">
            </picture>
        </td>
        <td style="text-align:left"><strong>2024-Feb</strong> Oncosyne presented at <a href="https://www.gowest.capital/">GoWest - Nordic Venture Capital Forum</a> in Gothenburg. Through collaborators, customers, and providers, Oncosyne is building connections to the thriving biotech ecosystem in <em>Västra Götaland</em>.
    </tr>
  

    <tr>
      <td style="text-align:right"><strong>2024-Feb</strong> Tone W. Trøen, Member of Parliament and Chair of <em>Helse- og omsorgskomiteen</em> visited the Oslo Cancer Cluster Incubator and Oncosyne's laboratories.
        <td style="text-align:left">
          <picture class="center-fit">
            <source type="image/webp" srcset="img/20240201_troen.webp">
            <img src="img/20240201_troen.webp" alt="Tone W. Trøen visiting Oncosyne, Photo: Oslo Cancer Cluster" width="150px" height="150px">
          </picture>
      </td>
    </tr>

    <tr>
      <td style="text-align:right">
        <picture class="center-fit">
          <source type="image/png" srcset="img/Forskningsradet_Stottet-logo_Engelsk_01_Weller_RGB.png">
          <img src="img/Forskningsradet_Stottet-logo_Engelsk_01_Weller_RGB.png" alt="NRC brand https://identitet.forskningsradet.no/verktoykasse/logo" width="150px" height="150px">
        </picture>
        <td style="text-align:left"><strong>2023-Dec</strong> Our project for in vitro diagnostic drug testing for pancreatic cancer was granted MNOK 16 in support through the <a href="https://www.forskningsradet.no/utlysninger/2023/innovasjonsprosjekt-i-naringslivet/#results" target="_blank" rel="noopener noreferrer"> Innovation Project for the Industrial Sector</a> program. The project is a collaboration with <a href="https://www.med.uio.no/hth/english/" target="_blank" rel="noopener noreferrer"> Hybrid Technology Hub</a> and <a href="https://www.sahlgrenska.se/en"> Sahlgrenska University Hospital</a>.
    </tr>
  
    <tr>
        <td style="text-align:right"><strong>2023-Nov</strong> MedWatch <a href="https://medwatch.no/nyheter/medtek_lab/article16598574.ece" target="_blank" rel="noopener noreferrer">publishes an interview</a> with CEO Jarle Bruun outlining company background, status and future plans (subscription paywall).</td>
        <td style="text-align:left">
            <picture class="center-fit">
              <source type="image/webp" srcset="img/medwatch-logo.webp" width="150px" height="150px">
              <img src="img/medwatch-logo.png" alt="" width="150px" height="150px">
            </picture>
    </tr>

    <tr>
        <td style="text-align:right"><img class="center-fit" src="img/radforsk.png" style="border-radius: 50%" alt="RADFORSK podcast" height="157" width="157"></td>
        <td style="text-align:left"><strong>2023-Oct</strong> Oncosyne's Jarle Bruun and Peter W. Eide guest the <em>Radium</em> podcast for a second time presenting plans for the coming years (<a href=https://soundcloud.com/user-972208711/episode-283radium target="_blank" rel="noopener noreferrer">episode 283</a>, Norwegian only).</td>
    </tr>

    <tr>
        <td style="text-align:right"><strong>2023-Aug</strong> Oncosyne finishes a research and development project paving way for clinical validation. We are grateful for financial support from <a href="https://www.regionaleforskningsfond.no/en/rff-oslo/" target="_blank" rel="noopener noreferrer">Regionale Forskningsfond Oslo</a> and contributions from Akershus University Hospital and <a href="https://www.helsinki.fi/en/researchgroups/precision-systems-medicine" target="_blank" rel="noopener noreferrer">Institue for Molecular Medicine</a>.</td>
          <td style="text-align:left">
          <picture class="center-fit">
            <source type="image/webp" srcset="img/230903_merge.webp" width="150px" height="150px">
            <img src="img/230903_merge.png" alt="" width="150px" height="150px">
          </picture>
    </tr>

    <tr>
        <td style="text-align:right">
            <video autoplay muted poster="img/3dculture.jpeg" width="150" height="150">
              <source src="mov/3dculture.webm" type="video/webm">
              <source src="mov/3dculture.mp4" type="video/mp4">
              "browser doesn't support WEBM or MP4 video"
            </video>
            <td style="text-align:left"><strong>2023-Jun</strong> Recruitment for the Tailoring Treatment in Colorectal Cancer (<a href="https://clinicaltrials.gov/study/NCT05401318" target="_blank" rel="noopener noreferrer">TargetCRC</a>) study is at 100% of the initial target of 40 patients. The first phase has been highly successful, and the target has been increased to a total of 80 patients.</td>
    </tr>


    <tr>
        <td style="text-align:right"><strong>2023-Apr</strong> Pharmaceutical company <a href="https://isofolmedical.com/" target="_blank" rel="noopener noreferrer">Isofol Medical</a> announces a collaboration with Oncosyne pairing Isofol's expertise in drug development with Oncosyne's platform for drug sensitivity evaluation.</td>
          <td style="text-align:left">
          <picture class="center-fit">
            <source type="image/webp" srcset="img/isofol.webp">
            <img src="img/isofol.png" alt="Cells in colors of the Swedish flag">
          </picture>
      </tr>

      <tr>
        <td style="text-align:right">
          <picture class="center-fit">
            <source type="image/webp" srcset="img/lab-new.webp">
            <img src="img/p8.png" alt="Culture drop">
          </picture>
        </td>
        <td style="text-align:left"><strong>2023-Jan</strong> Preparing for upcoming verification and production phases, Oncosyne moves its pipeline into a <em>dedicated</em> laboratory space at Oslo Cancer Cluster Incubator.
        </td>
      </tr>

      <tr>
        <td style="text-align:right"><strong>2022-Dec</strong> Oncosyne, Akershus University Hospital, and CTC receive funding through the <a href="https://www.eurekanetwork.org/countries/norway/eurostars/" target="_blank" rel="noopener noreferrer"> Eurostars-3 joint programme</a>. The grant supports technology development and a clinical peformance study.
          <td style="text-align:left">
            <picture class="center-fit">
              <source type="image/webp" srcset="img/eureka_round.webp">
              <img src="img/eureka_round.png" alt="Eureka logo" width="150px" height="150px">
            </picture>
        </td>
      </tr>
  
      <tr>
        <td style="text-align:right">
          <picture class="center-fit">
            <source type="image/webp" srcset="img/p8.webp">
            <img src="img/p8.png" alt="Culture drop">
          </picture>
        </td>
        <td style="text-align:left"><strong>2022-Nov</strong> Recruitment for the <em>Tailoring Treatment in Colorectal Cancer</em> (<a href="https://clinicaltrials.gov/study/NCT05401318" target="_blank" rel="noopener noreferrer">TargetCRC</a>) study is 50% completed and on schedule. An important study objective is to test Oncosyne's technology platform. The principal investigator is oncologist Dr. Sebastian Meltzer at Akershus University Hospital. 
        </td>
      </tr>


      <tr>
        <td style="text-align:right"><strong>2022-Sep</strong> Oncosyne presented at the <em>Rising Stars</em> session at the<a href="https://www.nlsdays.com/" target="_blank" rel="noopener noreferrer"> Nordic Life Science (NLS) Days</a> in Malmö 28-29th September.
          <td style="text-align:left">
            <picture class="center-fit">
              <source type="image/webp" srcset="img/nls-logo.webp">
              <img src="img/nls-logo.png" alt="Minister visiting Oncosyne, Photo: Oslo Cancer Cluster" width="150px" height="150px">
            </picture>
        </td>
      </tr>
  


      <tr>
        <td style="text-align:right">
          <picture class="center-fit">
            <source type="image/webp" srcset="img/vestre-visit.webp">
            <img src="img/vestre-visit.webp" alt="Minister visiting Oncosyne, Photo: Oslo Cancer Cluster">
          </picture>
        </td>
        <td style="text-align:left"><strong>2022-Aug</strong> In connection with <a href="https://oslocancercluster.no/2022/08/29/besokte-innovasjonsparken/" target="_blank" rel="noopener noreferrer">visiting the Oslo Cancer Cluster Innovation Park</a>, the Minister of Trade and Industry received a brief presentation in Oncosyne's laboratories.
        </td>
      </tr>


    <tr>
      <td style="text-align:right"><strong>2022-May</strong> Patient-derived microtumors are growing in the lab. These are indispensable for finalizing our diagnostic platform. We are grateful for the support from the participating patients and our clinical collaborators.
        <td style="text-align:left">
        <video autoplay muted loop poster="mov/zstack5.jpg" width="150" height="150">
          <source src="mov/zstack5.webm" type="video/webm">
          <source src="mov/zstack5.mp4" type="video/mp4">
          "browser doesn't support WEBM or MP4 video"
        </video>
      </td>
    </tr>

    <tr>
      <td style="text-align:right">
        <picture class="center-fit">
          <source type="image/webp" srcset="img/Barcode1_VisitOslo_Thomas_Johannessen-1024x682.webp">
          <img src="img/Barcode1_VisitOslo_Thomas_Johannessen-1024x682.jpg" alt="Barcode, Photo: Thomas Johannessen / oslobrandbox.no" height="157" width="157">
        </picture>
      </td>
      <td style="text-align:left"><strong>2022-Apr</strong> Oncosyne lands its first investment round financing development towards the registrational clinical trial. The investors significantly strengthen the Board's business experience.
      </td>
    </tr>

    <tr>
        <td style="text-align:right"><strong>2022-Mar</strong> Oncosyne's Jarle Bruun and Peter W. Eide guest the <em>Radium</em> podcast (<a href=https://soundcloud.com/user-972208711/episode-219 target="_blank" rel="noopener noreferrer">episode 219</a>, Norwegian only).</td>
        <td style="text-align:left"><img class="center-fit" src="https://i1.sndcdn.com/avatars-000706251061-hff07y-t500x500.jpg" style="border-radius: 50%" alt="RADFORSK podcast" height="157" width="157"></td>     
    </tr>

    <tr>
        <td style="text-align:right">
          <picture class="center-fit">
            <source type="image/webp" srcset="img/CityHall_VisitOslo_Thomas_Johannessen_crop.webp">
            <img src="img/CityHall_VisitOslo_Thomas_Johannessen_crop.png" alt="Oslo City Hall, Photo: Thomas Johannessen / oslobrandbox.no" height="157" width="157">
          </picture>
        </td>
        <td style="text-align:left"><strong>2022-Feb</strong> Oncosyne recieves a generous grant from <a href="https://www.regionaleforskningsfond.no/en/rff-oslo/" target="_blank" rel="noopener noreferrer">Regionale Forskningsfond Oslo</a> for clinical research and development of our diagnostic test platform.</td>
    </tr>

    <tr>
      <td style="text-align:right"><strong>2022-Jan</strong> We welcome M.Sc. Christer Anker Andreassen who is joining the team as product developer! Mr. Andreassen will help finalizing our platform for clinical studies.</td>
      <td style="text-align:left">
        <picture class="center-fit">
          <source type="image/webp" srcset="img/andreassen.webp">
          <img src="img/andreassen.png" alt="andreassen" width="157" height="157">
        </picture>
      </td>
    </tr>
        
    <tr>
      <td style="text-align:right">
      <video autoplay muted loop poster="mov/zstack1.jpg" width="130" height="150">
        <source src="mov/zstack1.webm" type="video/webm">
        <source src="mov/zstack1.mp4" type="video/mp4">
        "browser doesn't support WEBM or MP4 video"
      </video> 
      </td>
      <td style="text-align:left"><strong>2021-Dec</strong> Oncosyne finishes a successful research collaboration with Dr. Teijo Pellinen at <a href="https://www2.helsinki.fi/en/researchgroups/precision-systems-medicine/team#section-85703" target="_blank" rel="noopener noreferrer">FIMM</a>. The project was made possible through a generous grant from FORREGION-Oslo Aksershus/<a href="https://www.norwayhealthtech.com/" target="_blank" rel="noopener noreferrer">Norway Health Tech</a>/<a href="https://www.forskningsradet.no/en/" target="_blank" rel="noopener noreferrer">The Research Council of Norway</a>.</td>
    </tr>
    <tr>
      <td style="text-align:right"><strong>2021-Jun</strong> Oncosyne moves into <a href="https://occincubator.com/" target="_blank" rel="noopener noreferrer">OCCI</a>&rsquo;s shining laboratories. We are excited to become a part of this ambitious, dynamic growth environment.</td>
      <td style="text-align:left">
        <picture class="center-fit">
          <source type="image/webp" srcset="img/occi.webp">
          <img src="img/occi.png" alt="Oslo Cancer Cluster Incubator, Photo: Jarle Bruun" width="150" height="150">
      </picture>
    </td>
    </tr>
    </tbody>
  </table>
  <a href="#sec-ind-2" class="btn btn-circle js-scroll-trigger" aria-label="Scroll to Next Section"><i class="fa fa-angle-double-down animated"></i></a>
  </div></div></div>
</section>

<!-- SECTION 2 -->

<section id="sec-ind-2" class="section-2 content-section text-center">
  <div class="container"><div class="row"><div class="col-lg-8 mx-auto">
  <div class="improve-contrast-box-padded">
    <h2 id="about">About</h2>
  
    <body>
    <h6 id="problem">Problem</h6>
      <p style="text-align:justify">Cancer is a major burden and associated costs are increasing rapidly. There is an urgent need for better treatments, and new therapies are approved at an encouraging rate. However, diagnostic tools for selecting which drugs are likely to be effective or not for individual patients are lacking. Hence, oncological therapy is characterized by ubiquitous under- and over-treatment. In fact, most patients who are treated with chemotherapy receive no clinical benefit, but still suffer from harmful side-effects. This is not only detrimental to patients, but also hugely wasteful to healthcare systems and society.</p>
    <h6 id="solution">Solution</h6>
      <p style="text-align:justify"><em>In vitro</em> diagnostics based on clinical-grade drug screening has the potential to radically improve the therapeutic precision and efficacy in the treatment of most cancers. Crucially, it may pave the way for curative combination treatments in the future.</p> 
    <h6 id="company">Company</h6>
      <p style="text-align:justify">
        Oncosyne is a biotechnology start-up. Our clinical-stage technology platform will be evaluated in a performance study anticipated to start in 2024. In brief, we cultivate the patient’s own living cancer cells and test them against an array of clinically relevant drugs and drug combinations. The product is a diagnostic report that identifies both which cancer drugs are likely to be efficacious and which are not. The test will be marketed as a therapeutic decision tool towards pharmaceutical industry, medical laboratories, and public and private hospitals.</p>
    <h6 id="vision">Vision</h6>
      <p style="text-align:justify">Our vision is to provide game-changing functional diagnostic tools that give cancer patients significantly better and longer lives.</p>
    </body>
    <p></p>
    
    <a href="#sec-ind-3" class="btn btn-circle js-scroll-trigger" aria-label="Scroll to Next Section"><i class="fa fa-angle-double-down animated"></i></a>
  </div></div></div></div>
</section>

<!-- SECTION 3 -->

<section id="sec-ind-3" class="section-3 content-section text-center">
  <div class="container"><div class="row"><div class="col-lg-8 mx-auto">
    
  
  <h2 id="team">Team</h2>

  <div class="row">
    <div class="column">
      <div class="card">
        <div class="improve-contrast-box">
        <h5 id="bruun">Jarle Bruun</h5>
        <p class="title">CEO &amp; Co-founder</p>
      </div>
    </div>
  </div>

  <div class="column">
    <div class="card">
      <div class="improve-contrast-box">
        <h5 id="eide">Peter W. Eide</h5>
        <p class="title">CTO &amp; Co-founder</p>
      </div>
    </div>
  </div>

  <div class="column">
    <div class="card">
      <div class="improve-contrast-box">
        <h5 id="andreassen">Christer A. Andreassen</h5>
        <p class="title">Product Developer</p>
      </div>
    </div>
  </div>
</div> 

<h3 id="advisors">Advisors</h3>

  <div class="row">

    <div class="column">
      <div class="card">
        <div class="improve-contrast-box">
          <h5>Janne Nestvold</h5>
          <p class="title">Business advisor</p>
          <p>COO, Oslo Cancer Cluster Incubator</p>
        </div>
      </div>
    </div>
    
    <div class="column">
      <div class="card">
        <div class="improve-contrast-box">
          <h5>Thomas Andersson</h5>
          <p class="title">Business advisor</p>
          <p>Senior Business Advisor, Oslo Cancer Cluster Incubator</p>
        </div>
      </div>
    </div>

    <div class="column">
      <div class="card">
        <div class="improve-contrast-box">
            <h5>Øyvind S. Bruland</h5>
            <p class="title">Clinical advisor</p>
            <p>Professor of Clinical Oncology, University of Oslo</p>
        </div>
      </div>
    </div>
  </div>

  <div class="row">

    <div class="column">
      <div class="card">
        <div class="improve-contrast-box">
          <h5>Åke Andrén-Sandberg</h5>
          <p class="title">Clinical advisor</p>
          <p>Professor of surgery </p>
      </div>
    </div>
  </div>

  <div class="column">
    <div class="card">
      <div class="improve-contrast-box">
        <h5>Anette Sjögren</h5>
        <p class="title">Consultant, QMS</p>
        <p>Regulatory advisor, Preventia AB</p>
      </div>
    </div>
  </div>

  <div class="column">
    <div class="card">
      <div class="improve-contrast-box">
          <h5>TBD</h5>
          <p class="title"></p>
          <p></p>
      </div>
    </div>
  </div>




</div>

<a href="#sec-ind-5" class="btn btn-circle js-scroll-trigger" aria-label="Scroll to Next Section"><i class="fa fa-angle-double-down animated"></i></a>
</div></div></div></div>
</section>

<!-- CAREER -->

<section id="sec-ind-5" class="section-2 content-section text-center">

  <!-- <video autoplay muted loop id="background-video-section" poster="mov/gamol-changes.jpeg"> 
    <!-- webm video larger than mp4 
    <source src="mov/gamol-changes.mp4" type="video/mp4">
    "browser doesn't support WEBM or MP4 video"
  </video>  -->

  <div class="container"><div class="row"><div class="col-lg-8 mx-auto">
  <div class="improve-contrast-box-padded">
    <h2 id="careers">Careers</h2>
    <body>
    <p><a href="doc/202405_Oncosyne_We are hiring.pdf" target="_blank" rel="noopener noreferrer"> Open position autumn 2024</a>. Please let us know if you're interested in joining an ambitious biotech start-up and bring game-changing cancer diagnostic to the clinic.</p>
    <p>&nbsp;</p>
    <a href="#sec-ind-contact" class="btn btn-circle js-scroll-trigger" aria-label="Scroll to Next Section"><i class="fa fa-angle-double-down animated"></i></a>
    </body>
  </div>
  </div>
  
  </div>
</div>
</section>

<!-- SECTION CONTACT -->

<section id="sec-ind-contact" class="section-contact content-section text-center">
  <div class="container"><div class="row"><div class="col-lg-8 mx-auto">
  <div class="improve-contrast-box-padded">
  <h2 id="contact">Contact</h2>
  <p>Feel free to leave us an email at &#32;<span class="cloaked-e-mail" data-user="tsop" data-domain="on.enysocno" id="span-19eaafa4"></span>&#32;
  <script id="script-19eaafa4">
    var scriptTag = document.getElementById("script-19eaafa4");
    var link = document.createElement("a");
    var address = "tsop".split('').reverse().join('') + "@" + "on.enysocno".split('').reverse().join('');
    link.href = "mailto" + ":" + address; 
    link.innerText = address.split('?')[0];
    scriptTag.parentElement.insertBefore(link, scriptTag.previousElementSibling);
    scriptTag.parentElement.removeChild(scriptTag.previousElementSibling)
  </script>

  , or call us at 
  <style type="text/css">
    #span-020c3366.cloaked-e-mail:before {
      content:attr(data-user);
    unicode-bidi:bidi-override;
    direction:rtl;
  }
  </style>
  &#32;<span class="cloaked-e-mail" data-user="416 43 214 74&#43;" id="span-020c3366"></span>&#32;

  <script id="script-020c3366">
    var scriptTag = document.getElementById("script-020c3366");
    var link = document.createElement("a");
    var address = "416 43 214 74\u002b".split('').reverse().join('');
    link.href = "tel" + ":" + address;
    link.innerText = address.split('?')[0];
    scriptTag.parentElement.insertBefore(link, scriptTag.previousElementSibling);
    scriptTag.parentElement.removeChild(scriptTag.previousElementSibling)
  </script>

  . We have offices and laboratories at <a href="https://goo.gl/maps/f6WpPcjqUgxqTbVm8">Ullernchausséen 64, Oslo, Norway</a>.</p>
  </div>
  </div></div></div>
</section>

<!-- SECTION 5 -->

<footer>
  <div class="container text-center glowing">
    <p>&copy;2021-2024 Oncosyne AS | Org.no 926 191 942 </p>
  </div>
</footer>

<script src="https://oncosyne.no/vendor/jquery/jquery.min.js"></script>
<script src="https://oncosyne.no/vendor/bootstrap/js/bootstrap.bundle.min.js"></script>
<script src="https://oncosyne.no/vendor/jquery-easing/jquery.easing.min.js"></script>
<script src="https://oncosyne.no/js/grayscale.min.js"></script>

</body>
</html>
